Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The *physical barrier formation on the epidermal surface* involves the development of the outermost layer of skin—the stratum corneum—which acts as an air-liquid interface preventing excessive water loss from inside the body while blocking entry of harmful environmental agents such as chemicals, microbes, fungi, viruses, and ultraviolet radiation[2]. This multilayered structure arises during embryonic development through proliferation and differentiation processes where basal progenitor cells give rise sequentially through intermediate/spinous/granular cell layers culminating in cornified dead cells called corneocytes embedded within lipid lamellae[1][2]. Corneocytes are surrounded by specialized envelopes containing keratins associated with filaggrin-derived natural moisturizing factors that maintain hydration[2]. Tight junctions between granular layer cells form additional paracellular barriers limiting molecular passage[2]. The combined action creates both mechanical strength and selective permeability essential for homeostasis. Disruption or genetic defects affecting components like filaggrin lead to compromised barriers implicated in dermatological diseases such as atopic dermatitis[3]. In summary, "Physical barrier formation on epidermal surface" represents an essential physiological function mediated by coordinated cellular differentiation programs producing structural proteins (keratins), lipids secreted by granular cells forming impermeable layers between dead corneocytes in stratum corneum along with tight junction complexes sealing intercellular spaces. It is critical for protecting organisms from dehydration and environmental insults but does not correspond directly with any single canonical therapeutic molecular target.
Not applicable directly since this is not an individual drug target. Mechanisms relevant include: Enhancement of keratinocyte proliferation/differentiation pathways; Promotion of lipid synthesis/secretion for lamellar bodies; Tight junction protein expression regulation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Physical barrier formation on epidermal surface (None).